Regeneron shares slide on mixed trial data on smoker’s lung drug
(Reuters) -Regeneron shares fell nearly 13% before the bell on Friday after its experimental drug for patients with a type ...
Read moreDetails(Reuters) -Regeneron shares fell nearly 13% before the bell on Friday after its experimental drug for patients with a type ...
Read moreDetails
